CCL2 and type 2 diabetes mellitus: Plasma IL-6, IL-8, and MCP-1 levels are considerably enhanced in obese humans and in patients with insulin resistance, type 2 diabetes, and cardiovascular diseases (Skurk et al., 2002; Lyon and Hsueh, 2003).